(Q35116095)

6 August 2017

1 reference

title

Pharmacogenomics of primary hypertension--the lessons from the past to look toward the future (English)

1 reference

6 August 2017

1 reference

2

Jan A Staessen

1 reference

6 August 2017

1

Giuseppe Bianchi

1 reference

6 August 2017

Ferrari Patrizia

3

1 reference

6 August 2017

publication date

1 May 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

4

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

279-296

1 reference

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Cardiovascular protection and blood pressure reduction: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

ACE genotype and ACE inhibitor response in kidney disease: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Blood pressure-independent impact of antihypertensive agents on cardiovascular and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Molecular genetics of human blood pressure variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Genetics of blood pressure, hypertensive complications, and antihypertensive drug responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Seven lessons from two candidate genes in human essential hypertension: angiotensinogen and epithelial sodium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Pharmacogenomics of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Angiotensin II receptor polymorphisms in hypertension. Pharmacogenomic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Molecular mechanisms of human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Comparative effects of ACE inhibition and angiotensin II receptor blockade in the prevention of renal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Angiotensin I-converting enzyme gene polymorphism and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Elements of a paracrine tubular renin-angiotensin system along the entire nephron

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Role of the local renin-angiotensin system in cardiac damage: a minireview focussing on transgenic animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Local cardiac renin-angiotensin system: hypertension and cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Tissue renin-angiotensin system and end-organ damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Up-regulation of AT(1) and AT(2) receptors in postinfarcted hypertrophied myocytes and stretch-mediated apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

The DD-ACE genotype and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure : a critical review of current scientific evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Low sodium diet after DASH: has the situation changed? Dietary Approaches to Stop Hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Effect in the conscious dog of constriction of the renal artery to a sole remaining kidney on haemodynamics, sodium balance, body fluid volumes, plasma renin concentration and pressor responsiveness to angiotensin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Continuous angiotensin II blockade throughout the acute phase of one-kidney hypertension in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Effects of age on renal sodium homeostasis and its relevance to sodium sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Relationship between insulin resistance and nonmodulating hypertension: linkage of metabolic abnormalities and cardiovascular risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Salt consumption, reactive oxygen species and cardiovascular ageing: a hypothetical link

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Finding genes that underlie complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

The evolution of 'bricolage'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

The thrifty-genotype hypothesis and its implications for the study of complex genetic disorders in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Pathogenesis of arterial hypertension after the constriction of the renal artery leaving the opposite kidney intact both in the anaesthetized and in the conscious dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Signal transduction. History matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Renal function in relation to three candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Regulatory context is a crucial part of gene function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Time course of renal Na-K-ATPase, NHE3, NKCC2, NCC, and ENaC abundance changes with dietary NaCl restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

A bias-ed assessment of the use of SNPs in human complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Randomized, controlled trials, observational studies, and the hierarchy of research designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Genetic mapping and tailored antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Importance of the renin system for determining blood pressure fall with acute salt restriction in hypertensive and normotensive whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Association between hypertension and variation in the alpha- and beta-adducin genes in a white population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Cellular responses of identified lamprey central neurons to axonal and dendritic injury. An in situ model for studying cellular injury on the single cell level in the vertebrate CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Regulation of renal tubular sodium transport by angiotensin II and atrial natriuretic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Role of angiotensin converting enzyme genotype in sodium sensitivity in older hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Molecular basis of human hypertension: role of angiotensinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

M235T angiotensinogen gene polymorphism and cardiovascular renal risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Blood pressure is linked to salt intake and modulated by the angiotensinogen gene in normotensive and hypertensive elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Association of a human G-protein beta3 subunit variant with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Sodium-proton exchange and primary hypertension. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

The 825C/T polymorphism of the G-protein subunit beta3 is not related to hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

G-protein beta3 subunit 825T allele and response to dietary salt in normotensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Human genome sequence variation and the influence of gene history, mutation and recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Population genomics: a bridge from evolutionary history to genetic medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

The genetics of exceptional human longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Two point mutations within the adducin genes are involved in blood pressure variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Observations on the nature, biosynthesis, secretion and significance of endogenous ouabain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Endogenous cardiac glycosides, a new class of steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Adducin polymorphism affects renal proximal tubule reabsorption in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Lack of association between a biallelic polymorphism in the adducin gene and blood pressure in whites and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Na,K-ATPase activity in renal tubule cells from Milan hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

A molecular timescale for vertebrate evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

PST 2238: a new antihypertensive compound that modulates renal Na-K pump function without diuretic activity in Milan hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Molecular genetics of human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

ACE and α-Adducin Polymorphism as Markers of Individual Response to Diuretic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Carotid and femoral intima–media thickness in relation to three candidate genes in a Caucasian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Synergistic effect of α-adducin and ACE genes causes blood pressure changes with body sodium and volume expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Linkage but lack of association for blood pressure and the α-adducin locus in normotensive twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Will Genetics Revolutionize Medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Genotype to phenotype: associations, errors and complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

21 January 2018

Life-or-death decisions

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

A circulating inhibitor of (Na+ + K+) ATPase associated with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

On being a scientist. Committee on the Conduct of Science, National Academy of Sciences of the United States of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Unsolved problems in treating hypertension: rationale for new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Inadequate Management of Blood Pressure in a Hypertensive Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Heterogeneity of blood pressure response to dietary sodium restriction in normotensive adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Hypertension: genes and environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of renin-angiotensin system genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Diagnosis ex juvantibus. Individual response patterns to drugs reveal hypertension mechanisms and simplify treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Individual responses to converting enzyme inhibitors and calcium antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Association and linkage analysis of alpha-adducin polymorphism: is the glass half full or half empty?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Evidence for the existence of a functional cardiac renin-angiotensin system in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Renal ACE immunohistochemical localization in NIDDM patients with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

ADD1 460W Allele Associated With Cardiovascular Disease in Hypertensive Individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Renin system analysis: a rational method for the diagnosis and treatment of the individual patient with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Set point for sodium homeostasis: surfeit, deficit, and their implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Effects of Sodium Restriction on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterols, and Triglyceride

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Reversal of experimental renovascular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Hyperaldosteronism: primary versus tertiary

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Age-rated profile of cardiovascular reactivity to norepinephrine and angiotensin II in normal and hypertensive man

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Who's afraid of epistasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Two-locus linkage analysis in multiple sclerosis (MS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Analysis of the postulated interaction between the angiotensin II sub-type 1 receptor gene A1166C polymorphism and the insertion/deletion polymorphism of the angiotensin converting enzyme gene on risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

DD genotype of the angiotensin-converting enzyme gene and stroke in Slovenian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Truth survival in clinical research: an evidence-based requiem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Antihypertensive effect of various doses of hydrochlorothiazide and its relation to the plasma level of the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Relationship between the response to the angiotensin converting enzyme inhibitor imidapril and the angiotensin converting enzyme genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Association of the alpha-adducin locus with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Elevated concentrations of endogenous ouabain in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

The ADD1 G460W polymorphism is not associated with variation in blood pressure in Canadian Oji-Cree

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

Renal Na,K-ATPase in genetic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

17 beta-(3-furyl)-5 beta-androstane-3 beta, 14 beta, 17 alpha-triol (PST 2238). A very potent antihypertensive agent with a novel mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.4.3.279.22694

10.1517/PHGS.4.3.279.22694

21 January 2018

Identifiers

DOI

1 reference

release_wm6uagn3yreytixugw75cygy74

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wm6uagn3yreytixugw75cygy74

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference